Real-time enrollment status for this pulmonary disease, chronic obstructive clinical trial
Current Status
Recruiting
Checked: November 12, 2026 at 9:55 AM UTC
| NCT Number | NCT07759245 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Disease, Chronic Obstructive |
| Phase | PHASE2 |
| Target Enrollment | 606 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | November 5, 2026 (1 week ago) |
As of November 12, 2026: Clinical trial NCT07759245 is currently recruiting participants. This phase2 study for pulmonary disease, chronic obstructive is actively seeking new participants at 18 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07759245 is actively recruiting participants as of November 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07759245 was last updated 1 week ago (November 5, 2026). HelloStudys verifies this status automatically.